The art of aging well: a study of the relationship between recreational arts engagement, general health and mental wellbeing in cohort of Australian older adults

Autor: Christina R. Davies, Charley A. Budgeon, Kevin Murray, Michael Hunter, Matthew Knuiman

Publikováno v: Frontiers in Public Health, Vol 11 (2023)

IntroductionEvidence of the benefits of arts engagement to community wellbeing has been mounting since the 1990s. However, large scale, quantitative, epidemiological studies of the “arts–healthy aging” relationship, or the types of arts older a

Externí odkaz: https://doaj.org/article/71dec54227ec4a40a6034d4fd9eb3e83

Large Burden of Stroke Incidence in People with Cardiac Disease: A Linked Data Cohort Study

Autor: Keira Robinson, Judith M Katzenellenbogen, Timothy J Kleinig, Joosup Kim, Charley A Budgeon, Amanda G Thrift, Lee Nedkoff

Publikováno v: Clinical Epidemiology. 15:203-211

Keira Robinson,1 Judith M Katzenellenbogen,1 Timothy J Kleinig,2 Joosup Kim,3,4 Charley A Budgeon,1 Amanda G Thrift,4 Lee Nedkoff1,5 1School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia; 2D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c544cb7c6dc03d3a4cba014f83d93a28
https://doi.org/10.2147/clep.s390146

Developing PHarmacie-R: A bedside risk prediction tool with a medicines management focus to identify risk of hospital readmission

Autor: Benjamin Devine, Anthony Davidson, Shetaal Gupta, Christopher Etherton-Beer, Deirdre Criddle, Charley A. Budgeon, Rhonda Clifford, Frank M Sanfilippo, Kevin Murray

Publikováno v: Research in Social and Administrative Pharmacy. 18:3137-3148

Background The imperative to identify patients at risk of medication-related harm has never been greater. Hospital clinicians cannot easily predict risk of readmission or harm. Candidate variables associated with medication-related harm derived from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff8f4908076979cdee901ea4088659d6
https://doi.org/10.1016/j.sapharm.2021.08.014

The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial

Autor: Amber van Broekhoven, Niekbachsh Mohammadnia, Max J. M. Silvis, Jonathan Los, Aernoud T. L. Fiolet, Tjerk S. J. Opstal, Arend Mosterd, John W. Eikelboom, Stefan M. Nidorf, Charley A. Budgeon, Elizabeth Byrnes, Willem A. Bax, Jan G. P. Tijssen, Dominique P. V. de Kleijn, Peter L. Thompson, Saloua El Messaoudi, Jan H. Cornel

Publikováno v: Clinical drug investigation, 42(11), 977-985. Adis International Ltd
Clinical Drug Investigation, 42, 977-985
Clinical Drug Investigation, 42, 11, pp. 977-985

Contains fulltext : 288089.pdf (Publisher’s version ) (Open Access) BACKGROUND AND OBJECTIVE: The Low-Dose Colchicine-2 (LoDoCo2) trial showed that 2-4 years exposure to colchicine 0.5 mg once daily reduced the risk of cardiovascular events in pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7e75f557f8750b00f611a1192bac17
https://research.vumc.nl/en/publications/94450c2a-4c60-47b0-a72e-c9b9f640b416

Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome

Autor: Tjerk S.J. Opstal, Aernoud T.L. Fiolet, Amber van Broekhoven, Arend Mosterd, John W. Eikelboom, Stefan M. Nidorf, Peter L. Thompson, Michiel Duyvendak, J.W. Martijn van Eck, Eugène A. van Beek, Frank den Hartog, Charley A. Budgeon, Willem A. Bax, Jan G.P. Tijssen, Saloua El Messaoudi, Jan H. Cornel, S.M. Nidorf, X.F. Xu, M.A. Ireland, D. Latchem, A. Whelan, R. Hendriks, P. Salkani, I.W. Tan, A.G. Thompson, A.M. Morton, B.E. Hockings, P.L. Thompson, B. King, J.H. Cornel, H. Bakker-Lohmeijer, A. Mosterd, P. Bunschoten, S.H.K. The, S. van der Kooi, T. Lenderink, R.G.J.L. Lardinois, P.A.M. Hoogslag, A. de Vos, A. Jerzewski, S. Jansen, P.R. Nierop, M. van der Knaap, H.P. Swart, R. Kingma, J. Schaap, L.B. Blom, A.F.M. Kuijper, E. Bayraktar-Verver, M.W.J. van Hessen, W.C.T.C. Engelen, J.W.M. van Eck, N. van der Ven-Elzebroek, J.M.C. van Hal, I.M.J. Drost, F.R. den Hartog, D. van Wijk, E. van Beek, C. van der Horst, G.L. Bartels, M. Hendriks, C. de Nooijer, C. Welten, E. Ronner, A. Dijkshoorn, F.J. Prins, R.N.A. Rutten, D.P.W. Beele, I. Hendriks, A. van der Sluis, E.A. Badings, I.C.D. Westendorp, A. Melein, Tj.J. Römer, P. Bruines, R. van de Wal, I. Leenders - van Lieshout, M.E.W. Hemels, K. Meinen-Werner, M.R. de Groot, G. Post, M.W.C. Mulder, S. Stuij, E. van Nes, P. Luyten, J. Plomp, S.V. Veldmeijer, M.J. Asselman, P.A. Scholtus

Publikováno v: Journal of the American College of Cardiology, 78, 859-866
Journal of the American College of Cardiology, 78(9), 859-866. Elsevier USA
Journal of the American College of Cardiology, 78, 9, pp. 859-866
LoDoCo2 Trial Investigators 2021, ' Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome ', Journal of the American College of Cardiology, vol. 78, no. 9, pp. 859-866 . https://doi.org/10.1016/j.jacc.2021.06.037

Background: Colchicine reduces risk of cardiovascular events in patients post–myocardial infarction and in patients with chronic coronary disease. It remains unclear whether this effect is related to the time of onset of treatment following an acut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2add5dff1c86bc4cc654fd557da45ec2
http://www.scopus.com/inward/record.url?scp=85112566747&partnerID=8YFLogxK